Literature DB >> 19847143

How to diagnose and treat work-related asthma: key messages for clinical practice from the American college of chest physicians consensus statement.

Susan M Tarlo1, Gary M Liss, Paul D Blanc.   

Abstract

Work-related asthma is common among adult asthmatics, either asthma initially caused by work (occupational asthma) or pre-existing asthma worsened by work factors (work-exacerbated asthma). Appropriate management depends on both correct diagnosis and on recognition of etiology. Following a systematic literature review, the American College of Chest Physicians enpaneled a group of experts that reviewed this material, extended the literature review, and developed a "Consensus Statement on the Diagnosis, and Management of Work-Related Asthma", published in 2008. This article addresses the main practical aspects of that Consensus Statement, including clinical clues to diagnosis of work-related asthma from the medical history, exposure assessment, targeted diagnostic tests, and directed patient management. The range and importance of preventive measures are also addressed.

Entities:  

Mesh:

Year:  2009        PMID: 19847143

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  4 in total

Review 1.  Occupational asthma: an overview.

Authors:  Jessica Tan; Jonathan A Bernstein
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

Review 2.  Work-related asthma.

Authors:  Lavinia Clara Del Roio; Rafael Futoshi Mizutani; Regina Carvalho Pinto; Mário Terra-Filho; Ubiratan Paula Santos
Journal:  J Bras Pneumol       Date:  2021-08-11       Impact factor: 2.624

3.  Implementation of a Work-Related Asthma Screening Questionnaire in Clinical Settings: Multimethods Study.

Authors:  Madison MacKinnon; Max Moloney; Emma Bullock; Alison Morra; Teresa To; Catherine Lemiere; M Diane Lougheed
Journal:  JMIR Form Res       Date:  2022-09-15

4.  Work aggravated asthma in Great Britain: a cross-sectional postal survey.

Authors:  Lisa Bradshaw; Jade Sumner; Julian Delic; Paul Henneberger; David Fishwick
Journal:  Prim Health Care Res Dev       Date:  2018-04-12       Impact factor: 1.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.